Stroke Prevention and Treatment System in Shanghai: a Network of Public Healthcare of Stroke (SSSS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02735226 |
Recruitment Status : Unknown
Verified July 2017 by Qiang Dong, Shanghai Stroke Service System.
Recruitment status was: Recruiting
First Posted : April 12, 2016
Last Update Posted : July 19, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Stroke | Other: stroke network and policy intervention |
The goal of Shanghai stroke service system is to promote and facilitate high quality standardized stroke care in Shanghai area. The 11 hospitals involved are committed to provide the best stroke care to their patients. This quality goal consists of two parts: the acute phase of stroke care and the subsequent care during the hospitalization. To accomplish this goal, each hospital has organized a multidisciplinary stroke team that will address day-to-day stroke care. Each hospital provides prioritized neuroimaging service to patients with acute stroke 24hr per day, 7days per week. A stroke neurologist is on site 24hr per day, 7 days per week in each hospital. This team will follow the guidelines to carry out standardized secondary stroke prevention once the patient has been admitted.
The stroke clinical pathway is available on line in computers of each hospital. This pathway can be accessed from hospital computers, or from outside.
Stroke team members in each hospital obtained and entered all data on each stroke patient: demographics, stroke onset time, onset to thrombolytic time, presenting NIHSS, timing of diagnostic procedures, treatment strategies, performance of quality measures, comorbidities, in-hospital mortality, etc. These data are contained in a three-page form, which are embedded in the electronic health record of each patient.
If ICD-10 stroke codes were entered as the primary discharge diagnoses, the electronic health record systems would not allow the discharge of the patient until all required documentation has been completed. The EHR would not allow for any empty fields before it could be closed. Data quality was assured by automatic feasibility checks. The novel electronic data acquisition system provides the continuous clinical care data on all stroke patients from their acute management phase to inpatient rehabilitation or discharge.
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 100000 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 3 Months |
Official Title: | Shanghai Stroke Service System |
Study Start Date : | January 2014 |
Estimated Primary Completion Date : | December 2018 |
Estimated Study Completion Date : | December 2018 |
Group/Cohort | Intervention/treatment |
---|---|
Acute Stroke patient
Patients who are presented to hospital within 7days from onset. The key measurement of clinical quality controlled in patients with acute stroke managment and inhouse stroke care were record automatically
|
Other: stroke network and policy intervention
Shanghai stroke service and network contributes to update the ability of stroke care of comprehensive and primary stroke center,to improve radiation ability of comprehensive stroke centers and try to form a close relationship between comprehensive stroke centers and its primary stroke centers. |
- The acute stroke service and treatment provided in Shanghai area [ Time Frame: 5 years ]
The phase of acute stroke therapy. Under this category, the acute stroke care specific quality measurement items are:
Stroke onset to hospital ER Time
Door to CT Time
Door to seen by a doctor Time
Door to IV TPA Time
Door to groin puncture time for IA therapy
Door to admission to a hospital bed Time
- The secondary prevention of stroke provided after discharge in Shanghai area [ Time Frame: 5 years ]
2. Secondary stroke prevention prescribed.
Antithrombotics prescribed
Swallowing evaluation performed before oral feeding starts
DVT prophylaxis prescribed
Anticoagulation for atrial fibrillation prescribed
Brain imaging including vascular imaging performed
Stroke education provided
Educating patient to stop smoking
Statins prescribed
Rate of catheter related UTI
Rate of aspiration pneumonia
Hospital length of stay
Discharge destination
The time frame for this project is 5 years. All elements of acute stroke care will be collected during the hospital stay.
- To assess the rate of antiplatelet agent used for stroke prevention. [ Time Frame: 5 years ]This would include the rate of patients being prescribed dual antiplatelet therapy, and the duration/compliance of taking antiplatelet medicine.
- To assess the rate of using anticoagulant medication for stroke prevention in patients with atrial fibrillation. [ Time Frame: 5 years ]To assess the rate of bridging therapy used during hospitalization. Bridging therapy is to give intravenous or subcutaneous anticoagulation while waiting for warfarin to be therapeutic. In addition, the rate of prescribing new oral anticoagulants for stroke prevention in atrial fibrillation will be assessed,

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- 18 years old or older
- primary diagnosis as acute stroke or TIA within 7 days from onset
- admitted in stroke unit.
Exclusion Criteria:
- child or teenager younger than 18 years old
- woman with pregnant
- outpatient
- any other reason that patient cannot be admitted for secondary prevention

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02735226
Contact: Yi Dong, M.D | 86-21-52887145 | drdongyi@yeah.net | |
Contact: Kun Fang, M.D | 86-21-52887146 | drfrankhs@hotmail.com |
China, Shanghai | |
Zhongshan Hospital affiliated to Fudan University | Recruiting |
Shanghai, Shanghai, China, 200030 | |
Contact: Xin Wang, M.D.,Ph.D. 13501909896 wang.xin@zs-hospital.sh.cn | |
Principal Investigator: Xin Wang, M.D., Ph.D. | |
Huashan Hospital,Fudan University | Recruiting |
Shanghai, Shanghai, China, 200040 | |
Contact: Qiang Dong, M.D., Ph.D. 86-13701875129 qiang_dong163@163.com | |
Contact: Yi Dong, M.D. 86-13916665674 drdongyi@yeah.net | |
Sub-Investigator: Kun Fang, M.D. | |
Sub-Investigator: Yi Dong, M.D. | |
Shuguang Hospital affiliated to Shanghai Traditional Chinese Medicine University | Recruiting |
Shanghai, Shanghai, China, 200040 | |
Contact: Xiaofei Yu, M.D.,Ph.D. 13331978806 doctorxiaoyu@sina.com | |
Principal Investigator: Xiaofei Yu, M.D.,Ph.D. | |
The Shanghai Tenth People's Hospital, Tongji University | Recruiting |
Shanghai, Shanghai, China, 200072 | |
Contact: Xueyuan Liu 13564578127 lxyshtj@163.com | |
Principal Investigator: Xueyuan Liu, M.D. | |
Dongfang Hospital affiliated to Shanghai University of TCM | Recruiting |
Shanghai, Shanghai, China | |
Contact: Gang Li, M.D. 13621691786 ligang0531@yeah.net | |
Contact: Changsong Li 13122751682 kite1107@126.com | |
Principal Investigator: Gang Li, M.D. | |
Renji hospital,Shanghai Jiaotong University School of Medicine | Recruiting |
Shanghai, Shanghai, China | |
Contact: Yangtai Guan, Ph.D., M.D. 13386271865 yangtaiguan@hotmail.com | |
Contact: Ying Chen 13501763660 13501763660@163.com | |
Principal Investigator: Yangtai Guan, Ph.D., M.D. | |
Shanghai Changhai Hospital | Recruiting |
Shanghai, Shanghai, China | |
Contact: Benqiang Deng, M.D. 13701936570 13701936570@163.com | |
Principal Investigator: Benqiang Deng, M.D. | |
Shanghai Changzheng Hospital | Active, not recruiting |
Shanghai, Shanghai, China | |
Shanghai Jiao Tong University School of Medicine Ruijin Hospital | Recruiting |
Shanghai, Shanghai, China | |
Contact: Yi Fu 86-021-64370045 fuyiki@sina.com | |
Contact: Shufen Chen 1379532986 csf_cindy@hotmail.com | |
Principal Investigator: Yi Fu, M.D. | |
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine | Recruiting |
Shanghai, Shanghai, China | |
Contact: Jianren Liu, M.D. liujr021@vip.163.com liujr021@vip.163.com | |
Principal Investigator: Jianren Liu, M.D. | |
The Sixth People's Hospital affiliated to Shanghai Jiaotong University | Recruiting |
Shanghai, Shanghai, China | |
Contact: Yuwu Zhao, M.D. 15901713716 zhaoyuwu2005@126.com | |
Contact: Hongmei Wang 18930177606 dd-tt12345@163.com | |
Principal Investigator: Yuwu Zhao, M.D. |
Principal Investigator: | Qiang Dong, M.D., Ph.D | Shanghai Stroke Service System |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Qiang Dong, Director of Shanghai Stroke Service system, Shanghai Stroke Service System |
ClinicalTrials.gov Identifier: | NCT02735226 |
Other Study ID Numbers: |
Shanghai Stroke Service System |
First Posted: | April 12, 2016 Key Record Dates |
Last Update Posted: | July 19, 2017 |
Last Verified: | July 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | The data is planning to make individual participant data available, especially to anticipating collaborator. |
stroke Shanghai Healthcare Healthcare Quality, Access, and Evaluation |
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |